Does Arformoterol Tartrate Interact with Monoamine Oxidase Inhibitors Maois?
Arformoterol Tartrate and Monoamine Oxidase Inhibitors Maois have a major drug interaction according to U.S. FDA drug labeling data. May potentiate cardiovascular effects of arformoterol. Should be administered with extreme caution. The mechanism involves potentiation of adrenergic effects on cardiovascular system. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.
- Severity
- Major
- Management
- Close medical supervision required
- Data Source
- U.S. FDA via OpenFDA
How This Interaction Works
The interaction between Arformoterol Tartrate and Monoamine Oxidase Inhibitors Maois occurs because potentiation of adrenergic effects on cardiovascular system. Clinically, this means may potentiate cardiovascular effects of arformoterol. should be administered with extreme caution. This is classified as a major interaction, meaning it could cause serious harm if not properly managed. Your healthcare provider may need to adjust dosages, substitute one medication, or increase monitoring frequency.
What To Tell Your Doctor or Pharmacist
If you are taking Arformoterol Tartrate and your doctor is considering prescribing Monoamine Oxidase Inhibitors Maois (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask how frequently you should be monitored while these are co-prescribed
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider